Eric Sagonowsky

Associate Editor

Eric Sagonowsky is an associate editor with the FierceMarkets Life Sciences team. Before joining Fierce in November 2014, Eric worked as a news reporter for theManistee News Advocate in Manistee, Mich., covering government and crime issues. Eric graduated from Ohio University's E.W. Scripps School of Journalism in 2012 with a degree in Online Journalism. On campus, Eric wrote for The Athens News and The New Political. In his free time, Eric enjoys outdoor recreation, following sports of all kinds and exploring the metro D.C. area. He can be reached [email protected] Follow @EricSFierce on Twitter.

Stories by Eric Sagonowsky

Biotech seeks Big Pharma partner for universal flu shot: CEO

by Eric Sagonowsky

Tuesday, June 19, 2018

After reporting phase 2b results for FLU-v, SEEK Group CEO Gregory Stoloff said the program is ready for phase 3.

Sanofi recruits new CFO to replace outgoing Contamine

by Eric Sagonowsky

Tuesday, June 19, 2018

Sanofi's CFO search lasted two months and led the company to a financial executive from French automaker PSA Group.

ICCR touts support of first-year resolutions over exec pay, drug pricing

by Eric Sagonowsky

Monday, June 18, 2018

Some investors supported resolutions asking for more info about the link between drug prices and executive pay.

Dr. Reddy's forced to stop Suboxone generic rollout amid patent dispute

by Eric Sagonowsky

Monday, June 18, 2018

Dr. Reddy's moved ahead with an "at risk" launch of Indivior's top drug, but now a court has put the rollout on hold.

U.K. cost watchdogs turn away rare disease med Crysvita

by Eric Sagonowsky

Friday, June 15, 2018

Patients in the U.K. won't have access to X-linked hypophosphatemia med Crysvita under a ruling by NICE.

Attorney says J&J used law firm to hide contribution for talc safety article

by Eric Sagonowsky

Friday, June 15, 2018

An attorney for plaintiffs alleges Johnson & Johnson partially paid for a journal article on talc safety through a law firm.

Allergan swaps director position after investors demand change

by Eric Sagonowsky

Thursday, June 14, 2018

Rebel investors earlier this month called for changes at Allergan, and now the company has appointed a new director.

Massachusetts lawsuit names Purdue CEOs, Sackler family

by Eric Sagonowsky

Thursday, June 14, 2018

A lawsuit from Massachusetts is the first to target Purdue executives and directors, according to the state's attorney general.

Drug rebates should be history, HHS chief says

by Eric Sagonowsky

Wednesday, June 13, 2018

Drug rebates and list prices have been on a race to the top, and patients pay up. One solution, per HHS chief Alex Azar? Get rid of rebates entirely.

Sanofi, Translate Bio ink mRNA vaccine R&D deal worth up to $805M

by Eric Sagonowsky

Wednesday, June 13, 2018

The deal includes a $45 million upfront payment and R&D work in up to five undisclosed infectious disease targets.